Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

Aug 23, 2007

29777_dirs_2007-08-23_4e8c648b-76c0-492f-b3fb-1ba34f41e66c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-08-21

Reporting Person: GONZALEZ RICHARD A (Director, President and COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-08-21 Common shares without par value M 281530 $33.2314 Acquired 688950 Direct
2007-08-21 Common shares without par value F 219192 $52.39 Disposed 469758 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-08-21 Option (right to buy) $33.2314 M 281530 Disposed 2013-02-13 common shares (281530) Direct
2007-08-21 Option (right to buy) $52.39 A 219192 Acquired 2013-02-13 common shares (219192) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 18140 Indirect
Common shares without par value 7600 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 21, 2007.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife.

F3: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.